Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cytek Biosciences (CTKB) Change in Account Payables (2020 - 2025)

Historic Change in Account Payables for Cytek Biosciences (CTKB) over the last 6 years, with Q3 2025 value amounting to $588000.0.

  • Cytek Biosciences' Change in Account Payables fell 7360.86% to $588000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $2.0 million, marking a year-over-year increase of 28018.87%. This contributed to the annual value of $2.6 million for FY2024, which is 24473.09% up from last year.
  • Latest data reveals that Cytek Biosciences reported Change in Account Payables of $588000.0 as of Q3 2025, which was down 7360.86% from $759000.0 recorded in Q2 2025.
  • Over the past 5 years, Cytek Biosciences' Change in Account Payables peaked at $2.8 million during Q1 2022, and registered a low of -$2.0 million during Q2 2023.
  • Its 5-year average for Change in Account Payables is $219000.0, with a median of $305000.0 in 2023.
  • Its Change in Account Payables has fluctuated over the past 5 years, first soared by 238392.86% in 2022, then crashed by 32391.06% in 2023.
  • Over the past 5 years, Cytek Biosciences' Change in Account Payables (Quarter) stood at -$742000.0 in 2021, then fell by 22.37% to -$908000.0 in 2022, then crashed by 97.58% to -$1.8 million in 2023, then skyrocketed by 114.38% to $258000.0 in 2024, then skyrocketed by 127.91% to $588000.0 in 2025.
  • Its Change in Account Payables stands at $588000.0 for Q3 2025, versus $759000.0 for Q2 2025 and $410000.0 for Q1 2025.